OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma
Yun‐Fan Sun, Pin Wu, Zefan Zhang, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 135-156.e17
Closed Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Lactylome Analysis Unveils Lactylation‐Dependent Mechanisms of Stemness Remodeling in the Liver Cancer Stem Cells
Fan Feng, Jiaqin Wu, Qingjia Chi, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 39

Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 38

Advances in spatial transcriptomics and its applications in cancer research
Huazhe Yang, Yuanli Zuo, Gang Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 24

Tumour hypoxia in driving genomic instability and tumour evolution
Alexandru Suvac, Jack Ashton, Robert G. Bristow
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 3

Liver diseases: epidemiology, causes, trends and predictions
Can Gan, Yuan Yuan, Haiyuan Shen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3

Mechanisms and Strategies of Immunosenescence Effects on Non-Small Cell Lung Cancer (NSCLC) Treatment: A Comprehensive Analysis and Future Directions
Huatao Zhou, Zilong Zheng, Chengming Fan, et al.
Seminars in Cancer Biology (2025) Vol. 109, pp. 44-66
Closed Access | Times Cited: 2

Lactate Drives Senescence-Resistant Lineages in Hepatocellular Carcinoma via Histone H2B Lactylation of NDRG1
Lu Li, Jinyun Dong, Chunwei Xu, et al.
Cancer Letters (2025), pp. 217567-217567
Closed Access | Times Cited: 2

Maintaining first-line therapy plus radiotherapy may prolong progression-free survival and delay second-line therapy for oligoprogressive hepatocellular carcinoma
Boyu Leng, Haohua Wang, Yongbin Ge, et al.
International Journal of Radiation Oncology*Biology*Physics (2025)
Open Access | Times Cited: 1

Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention
Lin Tang, Peng Shen, Xiaoying Zhuang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1

Molecular mechanisms of m6A modifications regulating tumor radioresistance
Ruolin Shen, Zhenyang Jiang, Huanhuan Wang, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1

In vivo armed macrophages curb liver metastasis through tumor-reactive T-cell rejuvenation
Marco Notaro, Marco Borghetti, Chiara Bresesti, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1

Applications of single-cell multi-omics in liver cancer
Frederik Peeters, Sarah Cappuyns, Marta Piqué‐Gili, et al.
JHEP Reports (2024) Vol. 6, Iss. 7, pp. 101094-101094
Open Access | Times Cited: 7

Spatial oncology: Translating contextual biology to the clinic
Dennis Gong, Jeanna M Arbesfeld-Qiu, Ella Perrault, et al.
Cancer Cell (2024)
Closed Access | Times Cited: 6

Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment
Yanju Liu, Hongyuan Yang, Tian Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

Emerging trends and hot topics in the application of multi-omics in drug discovery: A bibliometric and visualized study
Ziheng Wang, Yang Zhao, Long Zhang
Current Pharmaceutical Analysis (2024) Vol. 21, Iss. 1, pp. 20-32
Open Access | Times Cited: 5

TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis
Jin Li, Ling Bai, Zhaodan Xin, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Optimizing interventional therapy: A homogeneous lipiodol formulation of Tirapazamine and Sorafenib responsive to post-embolization microenvironment
Xing Gao, Hongwei Cheng, Minglei Teng, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 879-889
Closed Access

Treatment for hepatocellular carcinoma after immunotherapy
Landon L. Chan, Tsz Tung Kwong, Jonathan Yau, et al.
Annals of Hepatology (2025), pp. 101781-101781
Open Access

Spatial‒temporal heterogeneities of liver cancer and the discovery of the invasive zone
Jiayan Yan, Zhifeng Jiang, Shiyu Zhang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access

Rutecarpine Suppresses Non‐Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8+ T Cells
Zebo Jiang, Qiang He, Liping Kang, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 2
Closed Access

Evolutionary paths towards metastasis
Kamila Naxerova
Nature reviews. Cancer (2025)
Closed Access

Resolving tumor evolution: a phylogenetic approach
Lin Li, Wenqin Xie, Li Zhan, et al.
Journal of the National Cancer Center (2024) Vol. 4, Iss. 2, pp. 97-106
Open Access | Times Cited: 3

Molecular insight into T cell exhaustion in hepatocellular carcinoma
Yonghua Zhu, Huabing Tan, Jincheng Wang, et al.
Pharmacological Research (2024) Vol. 203, pp. 107161-107161
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top